EASD 2025: Findings on Overweight, Obesity, and Glycemic Outcomes
At the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), held September 15 to 19,…
Clinical Research in Recent-Onset Type 1 Diabetes
In 2022, the drug teplizumab (Tzield®) was approved to delay the need for insulin therapy in people living with stage…
